The diagnosis of gastro-oesophageal reflux disease (GERD) in clinical practice is limited by the sensitivity and specificity of symptoms and diagnostic testing.
INTRODUCTION
A symptom-based diagnosis is of major practical importance for disease management in patients with gastrooesophageal reflux disease (GERD). However, the best options for symptom evaluation as an approach for diagnosing GERD have been studied relatively little and, as practised now, leave considerable room for improvement. 1 International consensus guidelines characterise GERD for research purposes based on the following symptoms: at least mild heartburn and/or regurgitation occurring on at least 2 days/week; or moderate/severe heartburn and/or regurgitation occurring on at least 1 day/week. 2 For clinical practice, the guidelines define GERD as the presence of 'troublesome' heartburn and/or regurgitation. 2 There is no single, gold standard investigation for GERD. 2, 3 Currently, the most objective reference standard for diagnosis is combined investigation with oesophageal endoscopy and pH monitoring to measure oesophageal acid exposure and its association with symptoms. Such investigation-based criteria were used to diagnose GERD in the Diamond study. 1 The Diamond study also included structured symptom assessment using the Reflux Disease Questionnaire (RDQ) and a pre-specified symptom checklist to measure the presence, severity and 'troublesomeness' of upper gastrointestinal symptoms. 1 In addition to the core reflux symptoms of heartburn and regurgitation, the study assessed symptoms of dyspepsia, including epigastric pain. Evaluable, standardised oesophageal histology data were available for a subset of patients from the Diamond study. A post hoc analysis showed that a total epithelial thickness of at least 430 lm in the distal oesophagus was the most robust histological marker for the presence of GERD diagnosed only on the basis of endoscopy and oesophageal pH monitoring. Epithelial hyperplasia correlated significantly with the presence of reflux oesophagitis, pathologic acid exposure, investigation-based GERD and nonerosive reflux disease. 4 The current analysis uses the symptom and histology data from the Diamond study to assess whether adding total epithelial thickness of at least 430 lm in addition to endoscopy and pH monitoring improves the yield for an investigation-based diagnosis of GERD and whether the diagnostic yield is affected by the presence or absence of epigastric pain.
METHODS

Study design
Our post hoc histology analyses were based on distal oesophageal biopsies from patients in the Diamond study (ClinicalTrials.gov Identifier: NCT00291746). 1 The Diamond study was a single-blind, single-arm study conducted in north-western Europe and Canada. 1 The study enrolled 507 patients, of whom 308 were suitable for the full primary analysis 1 and 336 were evaluable for exploratory analyses. [5] [6] [7] Our post hoc histology analyses were based on 231 (69%) of the 336 patients included in exploratory analyses who had biopsies that were assessed by a single pathologist (MV) and that were deemed evaluable for total epithelial thickness with regard to orientation and depth of biopsy.
Study population
The Diamond study recruited primary care patients aged 18-79 years who presented with frequent upper gastrointestinal symptoms. Individuals were included if they had not taken a proton pump inhibitor (PPI) in the past 2 months, and had experienced upper gastrointestinal symptoms of any severity on at least 2 days per week for at least 4 weeks before the start of the study and symptoms of at least mild severity on at least 3 days during the 7 days before study entry. Use of histamine-2 receptor antagonists was not allowed during the study period. Major exclusion criteria were: upper gastrointestinal endoscopy during the year before the study; previous anti-reflux surgery, surgery for a peptic ulcer or other gastrointestinal resection; daily use of acetylsalicylic acid (>165 mg/day) or nonsteroidal anti-inflammatory drugs (any dose); and alert features (e.g. dysphagia, weight loss, anaemia). 1 
Study investigations
Reflux oesophagitis (oesophageal mucosal breaks) was assessed using standard upper gastrointestinal endoscopy, and was identified and graded according to the Los Angeles (LA) classification. 8 For assessment of total epithelial thickness of the distal oesophageal mucosa, oesophageal biopsies were taken 2.0 cm above the Z-line in the 3 o'clock position, which has been shown previously to be the radial position in which erosions are predominantly visualised. 9 The distance of 2.0 cm from the Z-line was chosen because any gastric refluxate-induced changes would be expected to be less likely than if the biopsies were taken closer to the Z-line. 4 If mucosal breaks were visible, biopsies were taken from unbroken squamous epithelium 1.0 cm lateral from the edge of the mucosal break but at the same height above the Z-line. Total epithelial thickness was measured (in micrometres) at the assessment site for basal cell layer thickness (i.e. avoiding areas close to papillae and tangentially cut areas). 4, 10 The pathologist was blinded to the results of all other evaluations. Following endoscopy, oesophageal acid exposure and acid reflux episodes were measured using a wireless pHmonitoring capsule (Given Imaging, Yokneam, Israel), placed 6 cm above the endoscopically determined squamocolumnar junction. Oesophageal acid exposure was analysed for 24 h from midnight on the day of pH capsule placement to standardise the time window for pH data analysis. The symptom-acid association probability (SAP) 11 was determined over 24 h from midnight on the day the pH capsule was placed.
The frequency and severity of heartburn, regurgitation and dyspeptic symptoms were assessed at study entry using the RDQ. The RDQ is a 12-item, patient-reported outcome instrument that has undergone psychometric validation for evaluative and diagnostic purposes. 1, [12] [13] [14] The presence and severity of 19 upper gastrointestinal symptoms in the previous 7 days were assessed at study entry by physician interview using a pre-specified list, and patients were asked to identify their two most bothersome symptoms from this list. 1 
Diagnostic criteria
An investigation-based diagnosis of GERD was made when one or more of the following was present: reflux oesophagitis on endoscopy (LA classification grades A-D); pathological distal oesophageal acid exposure (oesophageal pH <4 for >5.5% of the time during the 24-h monitoring period); and positive SAP (≥95%) for association of symptoms with acid.
A symptom-based diagnosis of GERD was made according to international consensus guidelines when one or both of the following criteria was met: presence of at least mild heartburn and/or regurgitation on at least 2 days/week or at least moderate heartburn and/or regurgitation on at least 1 day/week (using data from the RDQ); and presence of heartburn and/or regurgitation as the most or second-most bothersome upper gastrointestinal symptom (using data from the physician interview). 2 Presence of epigastric pain was defined as epigastric pain of at least moderate severity on at least 1 day/week as reported on the RDQ.
Statistical analyses
Descriptive statistics were used to determine the proportions of patients meeting different diagnostic criteria. Fisher's exact test was used to determine the statistical significance of differences in the proportions of patients meeting criteria for investigation-based GERD and its component markers. A total epithelial thickness of at least 430 lm at 2.0 cm above the Z-line was assessed as an exploratory criterion for an investigation-based diagnosis of GERD.
The effect of the presence or absence of epigastric pain on the proportion of patients with a symptombased diagnosis of GERD who met criteria for an investigation-based diagnosis of GERD was assessed.
RESULTS
GERD diagnoses
Overall, 127 (55%) of the 231 patients included in this analysis met one or more of the three investigational criteria for a diagnosis of GERD: 85 patients (37%) met the acid exposure criteria, 69 (30%) met the endoscopic criteria and 36 (16%) met the SAP criteria. A total of 195 patients (84%) met the symptom-based GERD criteria ( Figure 1 ). Of the patients meeting symptom criteria, 118 (61%) met pH monitoring and/or endoscopic criteria for GERD: 66 had reflux oesophagitis, 80 had pathological oesophageal acid exposure and 35 had a positive SAP (Figure 2 ). The group used for this analysis was representative of the entire post hoc analysis population with regard to the proportion of individuals with an investigation-based or symptom-based GERD diagnosis ( Figure 1 ).
Oesophageal epithelial thickness
In total, 89 of 231 patients had a total epithelial thickness of at least 430 lm, of whom 61 (69%) met pH monitoring and/or endoscopic criteria for GERD and 83 (93%) met symptom-based criteria. Of individuals meeting symptom-based criteria who had a total epithelial thickness of at least 430 lm, 38 (46%) had reflux oesophagitis, 42 (51%) had pathological oesophageal acid exposure and 14 (17%) had a positive SAP (Figure 2) .
Using a total epithelial thickness of at least 430 lm as an exploratory criterion for diagnosis of GERD increased the number of patients diagnosed with GERD based on investigation by 28 (12%), from 127 patients (55%) to 155 patients (67%). These 28 patients had no reflux oesophagitis and no pathological oesophageal acid exposure, and had a negative SAP. The number needed to investigate to diagnose one additional patient with GERD by including histology is 8. The relative distributions of investigation-based GERD and its component markers in the presence and absence of a total epithelial thickness of at least 430 lm are shown in Table 1 . The relative proportion of patients meeting (or not meeting) criteria for investigation-based GERD and its component markers when including a total epithelial thickness of at least 430 lm was significantly different for reflux oesophagitis, pathological oesophageal acid exposure and investigation-based GERD (all P < 0.005), but not for a positive SAP.
Data on symptoms during 2 weeks' treatment with the PPI esomeprazole (40 mg daily) were available for 50 of the 89 patients with a total epithelial thickness of at least 430 lm and for 67 of the 142 patients with a total epithelial thickness less than 430 lm (the PPI test was defined as positive if the most bothersome upper gastrointestinal symptom was absent during the last 3 days of the treatment period 1 ). The number of patients with a recorded positive PPI test was 33 among patients with a total epithelial thickness of at least 430 lm (i.e. 37% of all patients in that group and 66% of those for whom data were available) and 41 among patients with a total epithelial thickness less than 430 lm (i.e. 29% of all patients in that group and 61% of those for whom data were available).
Epigastric pain
There was a significant difference in the proportion of patients with a symptom-based diagnosis of GERD who met criteria for an investigation-based GERD diagnosis, including total epithelial thickness of at least 430 lm, when concomitant epigastric pain was absent compared with when it was present. Specifically, criteria for an investigation-based diagnosis of GERD were met by 80% of patients who had frequent and/or severe reflux symptoms when concomitant epigastric pain was absent, compared with 67% when concomitant epigastric pain was present (P < 0.05). The number needed to investigate to diagnose one additional patient with GERD by excluding epigastric pain is 8. Of patients who had reflux symptoms as their most and/or second-most bothersome upper gastrointestinal symptom(s), 83% met pH or endoscopic or histological GERD criteria when concomitant epigastric pain was absent, compared with 73% when concomitant epigastric pain was present (P < 0.05).
DISCUSSION
In this analysis of histology data from primary care patients with frequent upper gastrointestinal symptoms, distal oesophageal epithelial hyperplasia and absence of epigastric pain increased the yield for a GERD diagnosis. The results suggest that assessment of epigastric pain can be used to enhance a symptom-based diagnosis of GERD before diagnostic testing. Adding histology (total epithelial thickness ≥430 lm in the distal oesophagus) has the potential to increase the yield at diagnostic testing. Diagnostic testing in a population in which a condition is widely prevalent is an economic challenge for most healthcare organisations. Improving the accuracy of symptom-based criteria for GERD is therefore an important goal of clinical research. Epigastric pain has been defined as a subclass of functional dyspepsia in the new Rome IV classification, 15 and previous studies have shown that acid inhibition is not very effective in this population. 16, 17 In one controlled trial, Helicobacter pylori- (85) N.S., not significant (P ≥ 0.05); SAP, symptom-acid association probability.
Study populations
* P value for relative proportion of patients meeting (or not meeting) criteria for investigation-based GERD and its component markers when including total epithelial thickness ≥430 lm as a criterion.
negative patients with epigastric pain or burning were randomised to treatment with a PPI or placebo. 16 At 4 weeks, the symptom response to PPI was 38% compared with a placebo response of 25% (P < 0.001). 16 Similar results were noted at 8 weeks, suggesting that acid inhibition has only a modest benefit compared with placebo in patients with epigastric symptoms. Our analysis supports the Rome IV classification and suggests that excluding patients with epigastric pain (of at least moderate severity on at least 1 day per week) may increase the sensitivity and specificity of testing for GERD. Clinicians and researchers can increase the pre-test probability for GERD diagnosed by symptoms or the probability for GERD by diagnostic tests by paying attention to epigastric pain or burning. All diagnostic testing modalities are affected by the pre-test probability of the underlying condition. In patients presenting with upper gastrointestinal symptoms, a clinical diagnosis and the choice of a diagnostic test depend on the clinician's pre-test assessment as to the probability of the disease being present. Refining symptom-based criteria to exclude patients with epigastric pain from the GERD diagnostic pathway may help increase the yield of diagnostic testing.
Histology has had mixed reviews as a diagnostic test for GERD. 18, 19 What is needed in clinical practice is a simple and reproducible tool that does not require expensive techniques such as electron microscopy. 20 Total epithelial thickness of at least 430 lm in the distal oesophagus, at 2.0 cm above the Z-line, has been shown in a previous Diamond study analysis to be the most robust histological marker for the presence of investigation-based GERD. 4 The position from which biopsies are taken in relation to the gastro-oesophageal junction is important when assessing total epithelial thickness: at 0.5 cm above the Z-line the specificity and sensitivity cut-off was 400 lm and was shown to have a lower overall efficiency value than the cut-off of 430 lm at 2.0 cm above the Z-line. 4 Several studies have found intercellular space dilatation, eosinophilic infiltration and papillary elongation to be markers for investigation-based GERD, but in all of these studies the control group comprised only asymptomatic individuals. [18] [19] [20] [21] [22] [23] [24] [25] All patients enrolled in the Diamond study had frequent upper gastrointestinal symptoms. In the Diamond study, dilated intercellular spaces lacked predictive power for investigation-based GERD, eosinophilic infiltration had good specificity but only low sensitivity and papillary elongation was predictive of investigation-based GERD in the overall study population but not in the subgroup without endoscopically recognisable reflux oesophagitis. 4 Histologically visible oesophageal lesions improve with treatment, but may take longer than reflux symptoms or endoscopically visible reflux oesophagitis to normalise. 26 The current analysis suggests that the presence of epithelial hyperplasia can increase the accuracy of diagnostic testing for GERD. Using total epithelial thickness of at least 430 lm in the distal oesophagus as a criterion (together with the standard, endoscopy and pH-monitoring-based criteria for investigation-based GERD) increased the diagnostic yield among the patients who underwent a biopsy by 12% (from 55% to 67%). Our data suggest that clinicians should consider obtaining histology when the pre-test probability for GERD is high and endoscopy does not reveal erosions. In patients free of oesophageal mucosal breaks who are found to have a hyperplastic oesophageal mucosa, measurement of epithelial thickness could save the added expense, discomfort and personal inconvenience of oesophageal pH monitoring. A recent study found that histology helped differentiate patients with functional heartburn from those with GERD. 27 The number of patients studied was
smaller than in the current analysis, but pH/impedance was used as the reference test and, therefore, the findings, which are consistent with ours, are of interest. Symptom-based GERD criteria were met by 84% of patients in the current analysis, whereas standard investigation-based criteria for GERD (based on oesophageal endoscopy and pH monitoring) were met by 55% of patients. This discrepancy suggests that, on the one hand, prevalence estimates based on symptom criteria for GERD may be an overestimation of the prevalence of GERD. On the other hand, it is also possible that the currently available panel of investigations for GERD fail to detect some patients with this disease. For example, they do not capture histopathological changes in the oesophagus that are not visible at routine endoscopy.
The current analysis was based on data from a relatively large, well defined primary care patient population. A carefully validated, widely used instrument (the RDQ) was used for symptom evaluation, investigational diagnostics included wireless oesophageal pH testing and a carefully tested criterion validated at two expert centres (total epithelial thickness ≥430 lm) 4 was used for histological evaluations. Limitations of our study include that it is a post hoc analysis and that pH-impedance testing was not used. Conventional oesophageal pH monitoring will not detect reflux episodes with a pH above 4 (i.e. includes weakly acidic reflux), some of which have been shown to cause symptoms, and their reliable measurement requires combined pH-impedance monitoring. 28 However, the role of pH-impedance testing has not been well studied in the initial diagnosis of GERD. It is still available in only a small number of centres and is not part of the mainstream toolkit used by most gastroenterologists. A recent systematic review of pH impedance concluded that important clinical and technical shortcomings limit its diagnostic value and must be considered when interpreting study results. 29 In contrast to earlier versions, the Rome IV criteria include patients with physiological acid exposure in the distal oesophagus and an abnormal SAP in the definition of functional heartburn. 30 This modification to the Rome criteria needs validation, but it should be noted that the number of patients with physiological acid exposure and a positive symptom association probability in our study was too small to influence the results.
In conclusion, excluding patients with moderate epigastric pain at least once a week from the case definition of GERD improves diagnostic accuracy. Adding histology improves the yield of diagnostic testing and should be considered when GERD is suspected but endoscopy is negative.
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